As quoted in the official website of the congress, “the engineering of lymphocytes is the wave of the future”. Indeed, thanks to the genetic manipulation of lymphocytes, great advances in the treatment of cancer and other types of diseases capable of being treated with this type of advanced therapies are being achieved in recent years.
VIVEbiotech sponsors the congress that has world-class speakers with whom we will interact. In addition, our Business Development Director, Dr. Natalia Elizalde, will attend a stand and give a talk entitled “Lentiviral vectors: safety and manufacturing related aspects“. In this intervention, she will share with the assistants the services offered by VIVEbiotech in the manufacture of lentiviral vectors, and will transmit the benefits offered in terms of stability by our own patented technology called Lentisoma.
You can get more information about this congress here.
